Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prothena Corp Public (PRTA) Cash & Equivalents: 2012-2025

Historic Cash & Equivalents for Prothena Corp Public (PRTA) over the last 13 years, with Sep 2025 value amounting to $330.8 million.

  • Prothena Corp Public's Cash & Equivalents fell 36.29% to $330.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $330.8 million, marking a year-over-year decrease of 36.29%. This contributed to the annual value of $471.4 million for FY2024, which is 23.83% down from last year.
  • Latest data reveals that Prothena Corp Public reported Cash & Equivalents of $330.8 million as of Q3 2025, which was down 10.93% from $371.4 million recorded in Q2 2025.
  • Prothena Corp Public's Cash & Equivalents' 5-year high stood at $710.4 million during Q4 2022, with a 5-year trough of $330.8 million in Q3 2025.
  • Its 3-year average for Cash & Equivalents is $532.4 million, with a median of $546.5 million in 2024.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first surged by 96.05% in 2021, then slumped by 36.29% in 2025.
  • Over the past 5 years, Prothena Corp Public's Cash & Equivalents (Quarterly) stood at $579.1 million in 2021, then rose by 22.68% to $710.4 million in 2022, then dropped by 12.89% to $618.8 million in 2023, then decreased by 23.83% to $471.4 million in 2024, then plummeted by 36.29% to $330.8 million in 2025.
  • Its last three reported values are $330.8 million in Q3 2025, $371.4 million for Q2 2025, and $417.9 million during Q1 2025.